Evidence map›Paper›PMID 18595975›Full record

Trial reportPediatrics2008

Effect of long-term corticosteroid use on bone mineral density in children: a prospective longitudinal assessment in the childhood Asthma Management Program (CAMP) study.

H William Kelly, Mark L Van Natta, Ronina A Covar, James Tonascia, Rebecca P Green, Robert C Strunk, CAMP Research Group

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Pediatrics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 7 pooled it
14.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 7 syntheses or guidelines pooled it, 187 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Patient- and parent-initiated oral steroids for asthma exacerbations.The Cochrane database of systematic reviews · 2016
    Pooled it
  5. Pooled it
  6. Nedocromil sodium for chronic asthma in children.The Cochrane database of systematic reviews · 2006
    Pooled it
  7. 2020 Brazilian Thoracic Association recommendations for the management of asthma.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia
    Guideline
  8. Trial
  9. Trial
  10. Trial
  11. Risk factors for montelukast treatment failure in step-down therapy for controlled asthma.The Journal of asthma : official journal of the Association for the Care of Asthma · 2011
    Trial
  12. Trial
  13. Trial
  14. Estimation of short-course systemic corticosteroid risks on adverse outcomes in childhood asthma.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

H William KellyDepartment of Pediatrics, University of New Mexico Health Sciences Center, Albuquerque, New Mexico 87131-0001, USA. hwkelly@salud.unm.edu
Mark L Van Natta
Ronina A Covar
James Tonascia
Rebecca P Green
Robert C Strunk
CAMP Research Group
Johns Hopkins University · USWashington University in St. Louis · USNational Jewish Health · USUniversity of New Mexico · US

Funding

ZOPOLRESTAT PHARMACOKINETICS IN DIABETICS WITH VARYING RENAL FUNCTIONM01RR000051 · NCRR · UNIVERSITY OF COLORADO DENVER · PI WALDERS, NATALIE · 1985 to 2008
$52.6M
ZUNI KIDNEY PROJECT STUDY I--POPULATION BASED SURVEY OF RENAL DISEASEM01RR000997 · NCRR · UNIVERSITY OF NEW MEXICO · PI LARSON, RICHARD S · 1985 to 2010
$30.0M
ZINC THERAPY FOR SCLERODERMA--PHASE I STUDYM01RR002719 · NCRR · JOHNS HOPKINS UNIVERSITY · PI EARLEY, CHRISTOPHER J · 1986 to 2007
$20.2M
CLINICAL CENTER FOR CAMPN01HR016049 · HR · BRIGHAM AND WOMEN'S HOSPITAL · PI WEISS, SCOTT T · 1991 to 2000
$1.0M
CLINICAL COORDINATING CENTER FOR CAMPN01HR016044 · HR · JOHNS HOPKINS UNIVERSITY · PI TONASCIA, JAMES A · 1991 to 2006
$729k
CLINICAL CENTER FOR CAMPN01HR016050 · HR · ASTHMA, INC. · PI SHAPIRO, GAIL G · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016051 · HR · WASHINGTON UNIVERSITY · PI STRUNK, ROBERT C · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016052 · HR · JOHNS HOPKINS UNIVERSITY · PI ADKINSON, N FRANKLIN · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016045 · HR · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI ZEIGER, ROBERT S · 1991 to 2001
$0k
CLINICAL CENTER FOR CAMPN01HR016046 · HR · UNIVERSITY OF NEW MEXICO · PI KELLY, H W · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016047 · HR · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI MACLUSKY, IAN B · 1991 to 2000
$0k
CLINICAL CENTER FOR CAMPN01HR016048 · HR · NATIONAL JEWISH HEALTH · PI SZEFLER, STANLEY J · 1991 to 2000
$0k
NCRR NIH HHS M01RR00051NCRR NIH HHS M01 RR000997NCRR NIH HHS M01RR0099718-24NCRR NIH HHS M01RR02719-14NCRR NIH HHS RR00036NHLBI NIH HHS N01-HR-16044NHLBI NIH HHS N01-HR-16045NHLBI NIH HHS N01-HR-16046NHLBI NIH HHS N01-HR-16047NHLBI NIH HHS N01-HR-16048NHLBI NIH HHS N01-HR-16049NHLBI NIH HHS N01-HR-16050NHLBI NIH HHS N01-HR-16051NHLBI NIH HHS N01-HR-16052
6 · The paper itself

Abstract

objectiveSystemic corticosteroids are known to induce osteoporosis and increase the risk for fractures in adults and children. Inhaled corticosteroids have been shown to increase the risk for osteoporosis and fractures in adults at risk; however, long-term prospective studies of children to assess risks of multiple short courses of oral corticosteroids and chronic inhaled corticosteroids have not been performed. Thus, we assessed the effects of multiple short courses of oral corticosteroids and long-term inhaled corticosteroids on bone mineral accretion over a period of years.

methodsThis was a cohort follow-up study for a median of 7 years of children who had mild-to-moderate asthma and initially were randomly assigned into the Childhood Asthma Management Program trial. Serial dual-energy radiograph absorptiometry scans of the lumbar spine for bone mineral density were performed for all patients. Annual bone mineral accretion was calculated for 531 boys and 346 girls who had asthma and were aged 5 to 12 years at baseline (84% of the initial cohort).

resultsOral corticosteroid bursts produced a dosage-dependent reduction in bone mineral accretion (0.052, 0.049, and 0.046 g/cm(2) per year) and an increase in risk for osteopenia (10%, 14%, and 21%) for 0, 1 to 4, and >or=5 courses, respectively, in boys but not girls. Cumulative inhaled corticosteroid use was associated with a small decrease in bone mineral accretion in boys but not girls but no increased risk for osteopenia.

conclusionsMultiple oral corticosteroid bursts over a period of years can produce a dosage-dependent reduction in bone mineral accretion and increased risk for osteopenia in children with asthma. Inhaled corticosteroid use has the potential for reducing bone mineral accretion in male children progressing through puberty, but this risk is likely to be outweighed by the ability to reduce the amount of oral corticosteroids used in these children.

Indexed as

AsthmaBone DensityBone Diseases, MetabolicChildChild, PreschoolDose-Response Relationship, DrugFemaleFractures, BoneGlucocorticoidsHumansMaleProspective StudiesSex FactorsGlucocorticoids

Identifiers

PMID18595975
PMCPMC2928657
OpenAlexW2132890998

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.